Bióloga pela Universidade Federal de Pernambuco (UFPE), com mestrado e doutorado em Biologia Celular e Molecular (BCM) pela Fundação Oswaldo Cruz. Doutorado sanduíche realizado na Georgia State University, Atlanta, USA. Atualmente é pesquisadora associada em saúde pública, e chefe do Laboratório de Investigação Cardiovascular, do Instituto Oswaldo Cruz, FIOCRUZ, e docente permanente do programa de Biologia Celular e Molecular, IOC/FIOCRUZ. É Jovem Cientista do Nosso Estado/FAPERJ (2021-2024) e sócia da Sociedade Brasileira de Farmacologia e Terapêutica Experimental (SBFTe). Tem como linha de pesquisa central a investigação de vias e mecanismos moleculares e fisiológicos envolvidos na patogênese de doenças cardio-metabólicas, como obesidade, síndrome metabólica, diabetes, doença hepática gordurosa não alcoólica e cardiopatia chagásica crônica. Estudo do papel da microcirculação nas doenças cardiovasculares, e possíveis alvos terapêuticos para essas doenças. Além disso, nos últimos anos estuda o envolvimento da via AGE-RAGE na etiologia de alterações hepáticas na diabetes e síndrome metabólica. Coordena a disciplina de pós-graduação "Doenças cardiovasculares e metabólicas: da bancada ao leito". É revisora de diversos periódicos de revistas internacionais indexadas. Desde 2020, é colaboradora do estudo longitudinal da saúde do brasileiro, ELSA-BRASIL. È também filiado ao Liver Center. Desenvolve projetos na área de inovação tecnológica, com desenvolvimento de dispositivo médico para aplicação em quantificação de esteatose hepática. É mãe de dois filhos, nascidos em 2014 e 2017. Realiza pesquisas pré-clínicas e clínicas.
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). His main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases. During 2017-2022, the focus period for evaluation of this proposal, Dr. Anissa and her team have: (i) received more than 15 awards, including a FAPERJ class 10 fellowship and honorable mentions and best presentations at national and international scientific congresses; (ii) have published 15 articles in high-impact journals, 7 of them as last author, and one review paper with dual authorship and corresponding author, and have 1 submitted article; (iii) have trained 7 master and 7 bachelor students. Currently, Dr. Anissa advises: 1 master's student and 5 doctoral students, 3 bachelor students, and has approved 1 student for PhD and 1 student for master's degree, and 1 student for postdoctoral fellow of CNPq. Since 2017, she has approved 3 projects as coordinator and participated in 3 as team member (Thematic projects/FAPERJ, Faperj/SES Covid, MCTIC/CNPq/FNDCT/MS/SCTIE). Currently, Dr. Anissa has 4 approved and ongoing funded projects (ARC /FAPERJ, CNPq/PROEP Clinical Research, INOVA Innovative Products, Young Scientist of Our State/FAPERJ and Thematic Projects/FAPERJ). It is worth noting that this study involves a multidisciplinary team from four different institutions, with a public-private partnership already in place with DASA.
